This inventor holds 2 USPTO granted patents. Top assignees: Andre Rosenthal, Metagen Pharmaceuticals Gmbh. Active years: 2002-2003.
Company Filing History:
Years Active: 2002-2003
Title: The Innovations of André Rosenthal
Introduction
André Rosenthal is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid sequences and their applications. With a total of 2 patents, his work has implications for both medical research and agricultural science.
Latest Patents
Rosenthal's latest patents include groundbreaking research on human nucleic acid sequences derived from endometrial tumor tissue. This patent describes mRNA, cDNA, and genomic sequences that code for gene products or portions thereof, along with their potential uses. Additionally, he has worked on the genomic sequence of the Rhizobium sp. NGR 234 symbiotic plasmid. This patent presents the complete nucleotide sequence of the symbiotic plasmid pNGR234a, including the identification of novel open reading frames (ORFs) and the proteins that can be expressed from them, which have been assigned putative functions.
Career Highlights
Throughout his career, André Rosenthal has been associated with several companies, including Metagen Pharmaceuticals GmbH. His work in these organizations has allowed him to further his research and contribute to advancements in biotechnology.
Collaborations
Rosenthal has collaborated with notable colleagues such as Thomas Specht and Bernd Hinzmann. These partnerships have enriched his research endeavors and expanded the impact of his inventions.
Conclusion
André Rosenthal's innovative work in biotechnology, particularly in the realm of nucleic acid sequences, showcases his significant contributions to science. His patents reflect a commitment to advancing medical and agricultural research, making him a prominent figure in his field.